Companies /Healthcare

VBI Vaccines Inc

NASDAQ: VBIV Biotechnology

$0.07

▲ $0.00 (+0.00%) today

Markets closed · 12:00am ET

Today · % change

Fundamentals

Market Cap

$1.9M

Revenue (TTM)

$9.4M

EPS (TTM)

$-3.54

Street Target

$5.00

About VBIV

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company is headquartered in Cambridge, Massachusetts.

VBIV Coverage

11:55am ET

Investing

Markets Pump the Brakes After Thursday Rally: Analysts Upgrade or Downgrade Intel, Occidental, Roku and More

Friday’s additional top analyst upgrades and downgrades were on Freeport-McMoRan, GSK, Intel, L3Harris Technologies, Occidental Petroleum, Roku, Six Flags Entertainment, Spirit AeroSystems, Sprouts Farmers Market, TuSimple and more.

FCX GDDY GSK

Chris Lange

11:45am ET

Investing

Wednesday Afternoon’s Analyst Upgrades and Downgrades: Inovio Pharmaceuticals, McDonald’s, VBI Vaccines, Wingstop and More

Wednesday afternoon's top analyst upgrades and downgrades included Inovio Pharmaceuticals, McDonald’s, Orchard Therapeutics, VBI Vaccines and Wingstop.

ALT CODX CTAS

Chris Lange